XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income (loss) $ 23,023 $ (615,083)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 604 751
Impairment of right-of-use assets 287 0
Stock-based compensation 2,588 43,880
Change in fair value of derivative liabilities – Class B Units 0 551,544
Change in fair value of derivative liabilities – other (7,131) 394
Deferred taxes 1,522 0
Unrealized gains on foreign currency (8) (10)
Noncash lease expense 478 448
Gain on sale of cryptocurrencies 0 (105)
Changes in operating assets and liabilities:    
Accounts receivable (8,607) (722)
Related party receivables and payables, net (164) 2,704
Prepaid expenses 1,334 (1,060)
Other current assets and other assets (259) 97
Cryptocurrency intangible assets 0 108
Deferred contract acquisition costs (3,649) (49,681)
Trade and other payables (2,388) (5,263)
Accrued expenses (5,416) 29,640
Deferred revenue 1,448 130,785
Operating lease liabilities (316) (276)
Other current and long-term liabilities (2,278) 4,153
Net cash provided by operating activities 1,068 92,304
Cash flows from investing activities:    
Cash paid for Chaikin acquisition, net of cash acquired 0 (7,139)
Purchases of property and equipment (14) (13)
Purchases of intangible assets 0 (662)
Capitalized software development costs (31) (20)
Net cash used in investing activities (45) (7,834)
Cash flows from financing activities:    
Issuance of related party notes receivable (4) (2)
Repurchases of stock (11,491) 0
Distributions to members 0 (13,917)
Distributions to noncontrolling interests (2,852) (250)
Net cash used in financing activities (14,347) (14,169)
Effect of exchange rate changes on cash (17) (16)
Net increase in cash, cash equivalents and restricted cash (13,341) 70,285
Cash, cash equivalents and restricted cash — beginning of period 139,578 114,927
Cash, cash equivalents and restricted cash — end of period $ 126,237 $ 185,212